Announcement of Joint Venture Establishment for Advancing Regenerative Medicine Business in China
Jun 22, 2022
Rohto Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Masashi Sugimoto, hereinafter”the Company”) is pleased to announce that it has entered into a joint venture agreement to establish a joint venture company in Hainan Island, China, in collaboration with several companies, including Global Biotechnology Company "Bloomage Concell Biotechnology（Hainan）Co.,Ltd." (Head Office: Hainan Province Haiguchi City; General Manager Mr. Ke Ding), Biomimetics Sympathies Co., Ltd. (Head Office: Koto-ku, Tokyo; Representative Director: Naoki Uruhata, hereinafter, "BioMimetics Sympathies").
Through this joint venture, the Company will promote regenerative medicine businesses, including the development, manufacturing, and sale of cell culture media.
Background of Establishment
Since its full-scale entry into the regenerative medicine field in 2013, the Company has been actively engaged in various developments to expand its business, such as the development of automated cell culture equipment, the development of cell products focusing on refractory diseases, and the launch of serum-free AOF medium for mesenchymal stem cells.Particularly, the cell culture media is expected to experience significant demand growth in parallel with the rapid expansion of the regenerative medicine sector worldwide.Moreover, the unstable international situation, including the pandemic, has underscored the importance of production and supply systems in various regions and countries.
Hainan Island, where the joint venture will be established, has introduced various key and preferential policies for the "medical field" as part of its development as a free trade zone, making it one of the strategic regions for regenerative medicine. Bloomage Concell Biotechnology, which has a strong track record and a powerful network in the country, has been adopted in important projects in this region. Together with BioMimetics Sympathies and the Company, which have already formed partnerships in joint development, we aim to rapidly promote the culture media business in China and work toward the development and sustainable growth of regenerative medicine businesses based on research and development by the newly established company.
Details of the Joint Venture Company
| Location |
State High-Tech Zone, Haiguchi City, Hainan Province |
| Business Activities |
Research and development, manufacturing, and sales of regenerative medical technology and cell culture media |
Future Outlook
The impact of this matter on the consolidated performance of the Company for the fiscal year ending March 2023 is expected to be minor. We will promptly announce any matters that should be disclosed.
About Bloomage Concell Biotechnology (Hainan) Co.,Ltd.
| Representative |
Legal Representative / General Manager Mr. Ke Ding |
| Location |
No.33 Ankang Street, Mei'an Ecological Technology New Town. Haikou National High-tech Industrial Development Zone, Haikou. Hainan. China |
| Business Activities |
Development and industrialization of biologically active substances such as functional sugars, proteins, polypeptides, amino acids, nucleotides, and natural active compounds in the fields of biotechnology and biomaterials |
| URL |
http://www.bloomagebioactive.com/index-e.html |
About BioMimetics Sympathies Inc.
| Representative |
President and Representative Director Naoki Urushibata |
| Location |
Koto-ku, Tokyo |
| Business Activities |
・Research development and clinical development related to cellular medicinal products
・Licensing out of products, intellectual properties, and rights related to regenerative medicine
・Cosmetics, reagents and culture medium business based on regenerative medicine technology
・Development of regenerative medicine-related businesses
|
| URL |
https://www.bm-s.biz/ |